BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12616032)

  • 21. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
    PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy.
    Sato M; Hotta O; Tomioka S; Horigome I; Chiba S; Miyazaki M; Noshiro H; Taguma Y
    Nephron Clin Pract; 2003; 93(4):c137-45. PubMed ID: 12759582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
    Choi S; Lee D; Jeong KH; Moon JY; Lee SH; Lee TW; Ihm CG
    Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.
    Stangou M; Papasotiriou M; Xydakis D; Oikonomaki T; Marinaki S; Zerbala S; Stylianou C; Kalliakmani P; Andrikos A; Papadaki A; Balafa O; Golfinopoulos S; Visvardis G; Moustakas G; Papachristou E; Kouloukourgiotou T; Kapsia E; Panagiotou A; Koulousios C; Kavlakoudis C; Georgopoulou M; Panagoutsos S; Vlahakos DV; Apostolou T; Stefanidis I; Siamopoulos K; Tzanakis I; Papadogiannakis A; Daphnis E; Iatrou C; Boletis JN; Papagianni A; Goumenos DS
    Clin Kidney J; 2018 Feb; 11(1):38-45. PubMed ID: 29423199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
    Kawasaki Y; Suyama K; Miyazaki K; Kanno S; Ono A; Suzuki Y; Sato M; Hashimoto K; Hosoya M
    Nephrology (Carlton); 2014 Jul; 19(7):384-91. PubMed ID: 24646214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K; Nakanishi K; Ito S; Saito M; Sako M; Ishikura K; Hataya H; Honda M; Iijima K; Yoshikawa N;
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
    Brown JH; Douglas AF; Murphy BG; Hill CM; McNamee PT; Nelson WE; Doherty CC
    Nephrol Dial Transplant; 1998 Feb; 13(2):443-8. PubMed ID: 9509460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
    Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
    Kobayashi Y; Hiki Y; Kokubo T; Horii A; Tateno S
    Nephron; 1996; 72(2):237-42. PubMed ID: 8684533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.
    Oshima S; Kawamura O
    Clin Exp Nephrol; 2008 Aug; 12(4):264-269. PubMed ID: 18324350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
    Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
    Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
    J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.